Your CDMO specialized in lentiviral vectors

Making the medicine of the future a reality

Our services

Experts in virology, we adapt ad-hoc to meet the specific requirements of your lentiviral vector.

Business model

GMP CDMO focused on different stages of the process.


We work exclusively in lentivirus, offering comprehensive services.

Customized service

Technical adaptation and timely slot availability for each project.

Quality and safety

Compliance with EMA and FDA regulatory requirements.

Trusted by industry leaders

Vivebiotech in data

+45 customers

in the US, Europe, Asia and Australia

4x greater batch capacity

in reactor since 2020

4x increase in staff

since 2018

7 rooms dedicated

exclusively to lentivirus production

70% hold PhDs or bachelor's degrees

combining young talent and experience

About us

We are a Contract Development and Manufacturing Organization (CDMO) with over 40 biotech companies worldwide that have placed their trust in us.

Read more

Our value

VIVEbiotech is one of the only companies in the world specialized exclusively in lentiviral vectors. One of the things that sets us apart is our expertise not only in production but also virology, backed by a team of professionals with more than 30 years of experience.

Read more
See all news

Last news

25 June 2024

VIVEbiotech participates in a roundtable article in Pharma’s Almanac

Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, participates in a roundtable article by Pharma's...

Read more

28 May 2024

IBTV interviews Natalia Elizalde during ASGCT´s annual meeting

Natalia Elizalde, Chief Business Development Officer of VIVEbiotech, was interviewed by IBTV during the ASGCT...

Read more

With the support of